KURA
#2385
Kura Oncology, Inc. - Common Stock
12.6 6 USD
-0.04%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.95%
Monthly Change
+33.69%
6 month change
+48.94%
Year Change
+58.45%
Previous Close
13.1 8
Open
12.6 6
Low
12.6 6
High
12.6 6
Volume
121
Financials
- Market Capitalization 1.13 B
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.27
Price to sales ratio
13.5
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2355 |  SANA Sana Biotechnology, Inc. - Common Stock | 3.93 USD | -3.91% | +1.29% | +20.18% | +30.56% | 1.18 B USD | ||
| 2371 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.38 USD | -6.56% | -4.56% | -11.92% | +18.41% | 1.14 B USD | ||
| 2402 |  JANX Janux Therapeutics, Inc. - Common Stock | 18.03 USD | -3.99% | +1.86% | +15.95% | -21.13% | 1.10 B USD | ||
| 2414 |  SVRA Savara, Inc. - Common Stock | 5.26 USD | -4.19% | -6.07% | -5.05% | +60.37% | 1.08 B USD |
Frequently asked questions about Kura Oncology, Inc.
What is the Kura Oncology, Inc. stock price today?
The current price of Kura Oncology, Inc. (KURA) is 12.66. Over the past 24 hours, the stock has changed by -3.95%. Follow the KURA chart for real-time price dynamics.
What is the stock ticker of Kura Oncology, Inc.?
Kura Oncology, Inc. trades under the ticker KURA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kura Oncology, Inc. stock going up?
KURA has changed by +7.56% over the last week, +33.69% over the last month, and +58.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kura Oncology, Inc.?
Kura Oncology, Inc. currently has a market capitalization of 1.13 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kura Oncology, Inc. earnings last quarter?
Last quarter, Kura Oncology, Inc. reported earnings of -0.77 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kura Oncology, Inc. revenue for the last quarter?
Kura Oncology, Inc. reported quarterly revenue of 20.87 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Kura Oncology, Inc. net income for the last quarter?
Kura Oncology, Inc. reported net income of -68.33 M for the last quarter. The previous quarter showed -73.33 M, which means net income changed by +6.83%.
How many employees does Kura Oncology, Inc. have?
As of the latest available data, Kura Oncology, Inc. has 260 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kura Oncology, Inc. EBITDA?
Kura Oncology, Inc. EBITDA is -73.27 M, and its EBITDA margin is -351.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kura Oncology, Inc. stock?
You can buy Kura Oncology, Inc. (KURA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kura Oncology, Inc. stock?
Investing in Kura Oncology, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KURA chart and related analysis on metatrader.com as part of your research.